Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif

Nature Structural and Molecular Biology

Volumn 15, Issue 11, 2008, Pages 1184-1191

  Shirakawa, Kotaro ^a,b   Takaori Kondo, Akifumi ^a   Yokoyama, Masaru ^c   Izumi, Taisuke ^a   Matsui, Masashi ^a   Io, Katsuhiro ^a   Sato, Toshihiro ^d   Sato, Hironori ^c   Uchiyama, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b The Japan Foundation   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d JAPAN TOBACCO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; ARGININE; CYCLIC AMP DEPENDENT PROTEIN KINASE; NUCLEIC ACID BINDING PROTEIN; THREONINE; VIF PROTEIN;

ARTICLE; BINDING KINETICS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; MOLECULAR MODEL; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; UBIQUITINATION;

ARGININE; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTIDINE DEAMINASE; GENE PRODUCTS, VIF; HIV-1; HUMANS; MODELS, MOLECULAR; MUTATION; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; THREONINE; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 55549136017     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.1497     Document Type: Article

References (37)

1. Harris, R.S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809 (2003).
2. Mangeat, B. et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103 (2003).
3. Zhang, H. et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98 (2003).
4. Shindo, K. et al. The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity. J. Biol. Chem. 278, 44412-44416 (2003).
5. Sheehy, A.M., Gaddis, N.C., Choi, J.D. & Malim, M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650 (2002).
6. Kobayashi, M., Takaori-Kondo, A., Miyauchi, Y., Iwai, K. & Uchiyama, T. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. J. Biol. Chem. 280, 18573-18578 (2005).
7. Shirakawa, K. et al. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex. Virology 344, 263-266 (2006).
8. Honjo, T., Kinoshita, K. & Muramatsu, M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 20, 165-196 (2002).
9. Basu, U. et al. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438, 508-511 (2005).
10. Pasqualucci, L., Kitaura, Y., Gu, H. & Dalla-Favera, R. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl. Acad. Sci. USA 103, 395-400 (2006).
11. Shabb, J.B. Physiological substrates of cAMP-dependent protein kinase. Chem. Rev. 101, 2381-2411 (2001).
12. Aandahl, E.M. et al. Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. FASEB J. 12, 855-862 (1998).
13. Cole, S.W., Jamieson, B.D. & Zack, J.A. cAMP up-regulates cell surface expression of lymphocyte CXCR4: implications for chemotaxis and HIV-1 infection. J. Immunol. 162, 1392-1400 (1999).
14. 2 inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cell. Immunol. 215, 61-71 (2002).
15. 2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 92, 40-45 (1998).
16. Rabbi, M.F., Al-Harthi, L. & Roebuck, K.A. TNFa cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements. Virology 237, 422-429 (1997).
17. Rabbi, M.F., al-Harthi, L., Saifuddin, M. & Roebuck, K.A. The cAMP-dependent protein kinase A and protein kinase C-β pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage. Virology 245, 257-269 (1998).
18. Cartier, C. et al. Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein. J. Biol. Chem. 278, 35211-35219 (2003).
19. Li, P.L. et al. Phosphorylation of HIV Nef by cAMP-dependent protein kinase. Virology 331, 367-374 (2005).
20. Hofmann, B., Nishanian, P., Nguyen, T., Insixiengmay, P. & Fahey, J.L. Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc. Natl. Acad. Sci. USA 90, 6676-6680 (1993).
21. Xu, H. et al. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. USA 101, 5652-5657 (2004).
22. Mangeat, B., Turelli, P., Liao, S. & Trono, D. A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J. Biol. Chem. 279, 14481-14483 (2004).
23. Bogerd, H.P., Doehle, B.P., Wiegand, H.L. & Cullen, B.R. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. USA 101, 3770-3774 (2004).
24. Schrofelbauer, B., Chen, D. & Landau, N.R. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. USA 101, 3927-3932 (2004).
25. Huthoff, H. & Malim, M.H. Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation. J. Virol. 81, 3807-3815 (2007).
26. Chen, K.M. et al. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G. Nature 452, 116-119 (2008).
27. Prochnow, C., Bransteitter, R., Klein, M.G., Goodman, M.F. & Chen, X.S. The APOBEC-2 crystal structure and functional implications for the deaminase AID. Nature 445, 447-451 (2007).
28. Mulder, L.C., Harari, A. & Simon, V. Cytidine deamination induced HIV-1 drug resistance. Proc. Natl. Acad. Sci. USA 105, 5501-5506 (2008).
29. Kobayashi, M. et al. APOBEC3G targets specific virus species. J. Virol. 78, 8238-8244 (2004).
30. Strebel, K. et al. The HIV A (sor) gene product is essential for virus infectivity. Nature 328, 728-730 (1987).
31. Simon, J.H., Southerling, T.E., Peterson, J.C., Meyer, B.E. & Malim, M.H. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J. Virol. 69, 4166-4172 (1995).
32. Pham, P., Bransteitter, R. & Goodman, M.F. Reward versus risk: DNA cytidine deaminases triggering immunity and disease. Biochemistry 44, 2703-2715 (2005).
33. Conticello, S.G., Thomas, C.J., Petersen-Mahrt, S.K. & Neuberger, M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol. 22, 367-377 (2005).
34. Baker, D. & Sali, A. Protein structure prediction and structural genomics. Science 294, 93-96 (2001).
35. Oka, T. et al. Highly conserved configuration of catalytic amino acid residues among calicivirus-encoded proteases. J. Virol. 81, 6798-6806 (2007).
36. Song, H. et al. A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5as. J. Virol. 81, 7280-7285 (2007).
37. Ponder, J.W. & Case, D.A. Force fields for protein simulations. Adv. Protein Chem. 66, 27-85 (2003).